The Montreal Cognitive Assessment as a preliminary assessment tool in general psychiatry. Validity of MoCA in psychiatric patients.

General Hospital Psychiatry

Volumn 37, Issue 5, 2015, Pages 476-480

  Gierus, J ^a,b,c   Mosiolek A ^a,b   Koweszko, T ^a,b   Wnukiewicz, P ^a   Kozyra, O ^a   Szulc, A ^a,b  

^a Jan Mazurkiewicz Mazovia Specialist Health Centre   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c NONE   (Poland)

Author keywords

Cognitive assessment; Montreal Cognitive Assessment (MoCA); Psychiatric patients

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFIER; COGNITIVE DEFECT; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CRITERION RELATED VALIDITY; DIAGNOSTIC ACCURACY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; MOOD DISORDER; NEUROSIS; PERSONALITY DISORDER; PSYCHOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; ADOLESCENT; COGNITION DISORDERS; MENTAL PATIENT; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHIATRY; PSYCHOLOGY; QUESTIONNAIRE; STANDARDS; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MENTALLY ILL PERSONS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRY; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84941261562     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.05.011     Document Type: Article

References (38)

1. Herzyk A. Diagnoza neuropsychologiczna - dokąd zmierza? Pytania, polemiki, propozycje rozwiązań. Diagnoza Neuropsychologiczna 2000, 23-50. UMCS, Lublin. A. Borkowska, E.D. Szepietowska (Eds.).
2. Jodzio K. Diagnostyka psychologiczna w praktyce klinicznej 2011, Wydawnictwo Difin, Warszawa, [390 pp].
3. Vinogradov S., Fisher M., Nagarajan S. Cognitive training in schizophrenia: golden age or wild west?. Biol Psychiatry 2013, 73(10):935-937.
4. Subramaniam K., Luks T.L., Fisher M., Simpson G.V., Srikantan N., Vinogradov S. Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron 2012, 73(4):842-853.
5. Scrimali T. Entropy of Mind and Negative Entropy. A Cognitive and Complex Approach to Schizophrenia and Its Therapy 2008, Karnac Books, London.
6. Van Rheenen T.E., Rossell S.L. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder. Bipolar Disord 2014, 16(3):318-325.
7. Hurford I.M., Marder S.R., Keefe R.S., Reise S.P., Bilder R. A Brief Cognitive Assessment Tool for Schizophrenia: construction of a tool for clinicians. Schizophr Bull 2011, 37(3):538-545.
8. Ihl R., Grass-Kapanke B., Jänner M., Weyer G. Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS-cog, SKT and MMSE. Pharmacopsychiatry 1999, 32:248-254.
9. Clark S.M., Sheppard L., Fillenbaum G.G., Galasko D., Morris J.C., Koss E., et al. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1999, 56:857-862.
10. White N., Scott A., Woods R.T., Wenger G.-C., Keady J.-D., Devakumar M. The limited utility of the Mini-Mental State Examination in screening people over the age of 75years for dementia in primary care. Br J Gen Pract 2002, 52:1002-1003.
11. Osafune M., Deguchi K., Abe K. Ideal combination of dementia screening tests. Nihon Ronen Igakkai Zasshi 2014, 51(2):178-183.
12. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53(4):695-699.
13. Gill D.J., Freshman A., Blender J.A., Ravina B. The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord 2008, 23:1043-1046.
14. Hoops S., Nazem S., Siderowf A.D., Duda J.E., Xie S.X., Stern M.B., et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009, 73:1738-1745.
15. Olson R.A., Chanabhai T., McKenzie M. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Support Care Cancer 2008, 16:1273-1278.
16. Fisekovic S., Memic A., Pasalic A. Correlation between MoCA and MMSE for the assessment of cognition in schizophrenia. Acta Inform Med 2012, 20(3):186-189.
17. PredaA Adami A., Kemp A.S., Nguyen D. MoCA: a screening instrument for the assessment of cognition in schizophrenia. Schizophr Bull 2011, 37:225-226.
18. Gagnon J.F., Postuma R.B., Joncas S., Desjardins C., Latreille V. The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder. Mov Disord 2010, 25(7):936-940.
19. Musso M.W., Cohen A.S., Auster T.L., McGovern J.E. Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness. Psychiatry Res 2014, 10.1016/j.psychres.2014.07.078.
20. Arunpongpaisal S., Sangsirilak A. Using MoCA-Thai to evaluate cognitive impairment in patients with schizophrenia. J Med Assoc Thai 2013, 96(7):860-865.
21. Magierska J., Magierski R., Fendler W., Kłoszewska I., Sobów T.M. Clinical application of the Polish adaptation of the Montreal Cognitive Assessment (MoCA) test in screening for cognitive impairment. Neurol Neurochir Pol 2012, 46:130-139.
22. Gierus J., Mosiołek A., Kozyra O., Wnukiewicz P., Koweszko T. Montrealska Skala Oceny Funkcji Poznawczych MoCA 7.2. - adaptacja metody i badania nad równowaz˙nością. Psychiatr Pol. 2015, 49(1):171-179.
23. Zipursky R.B., Reilly T.J., Murray R.M. The myth of schizophrenia as a progressive brain disease. Schizophr Bull 2013, 39(6):1363-1372.
24. Zaburzenia funkcji poznawczych w chorobach psychicznych 2005, Biblioteka Psychiatrii Polskiej, Kraków. A. Borkowska (Ed.).
25. Testa R., Wood S.J., Pantelis Ch. Schizophrenia. The Neuropsychology of Mental Illness 2009, 378-388. Cambridge University Press, New York. S.J. Wood, N.B. Allen, C. Pantelis (Eds.).
26. Darby D., Walsh K. Walsh's Neuropsychology: A Clinical Approach 2005, Elsevier Churchill Livingstone, Edinburgh.
27. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992, World Health Organization, World Health Organization, Geneva.
28. Yücel M., Lubman D.I., Solowij N., Brewer W.J. Neurobiological and neuropsychological pathways into substance abuse and addictive behavior. The Neuropsychology of Mental Illness 2009, 326-341. Cambridge University Press, New York. S.J. Wood, N.B. Allen, C. Pantelis (Eds.).
29. Gould T.J. Addiction and cognition. Addict Sci Clin Pract 2010, 5(2):4-14.
30. Keedwell P., Sunguladze A., Philips M. Neuropsychological investigation in mood disorders. The Neuropsychology of Mental Illness 2009, 353-364. Cambridge University Press, New York. S.J. Wood, N.B. Allen, C. Pantelis (Eds.).
31. Marvel Ch.L., Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 2004, 27(1):19-36.
32. Depue R.A. A multidimensional neurobehavioral model of personality disorders. The Neuropsychology of Mental Illness 2009, 300-315. Cambridge University Press, New York. S.J. Wood, N.B. Allen, C. Pantelis (Eds.).
33. Rodríguez-Bores Ramírez L., Saracco-Álvarez R., Escamilla-Orozco R., Fresán Orellana A. Validity of the Montreal Cognitive Assessment Scale (MoCA) for the detection of cognitive impairment in schizophrenia. Salut Ment 2014, 37:485-490.
34. Memória C.M., Yassuda M.S., Nakano E.Y., Forlenza O.V. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry 2013, 28(1):34-40.
35. Karunaratne S., Hanwella R., de Silva V. Validation of the Sinhala version of the Montreal Cognitive Assessment in screening for dementia. Ceylon Med J 2011, 56(4):147-153.
36. Larner A. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of or as well as the MMSE?. Int Psychogeriatr 2012, 24(3):391-396.
37. Montiel J.M., Cecato J.F., Bartholomeu D., Martinelli J.E. Evaluation of Montreal cognitive assessment for the differential diagnosis of mild cognitive impairment and Alzheimer's disease in elderly patients with more than 5years of schooling: data from a Brazilian sample. AAR 2013, 2(4):121-129.
38. Sharma T. Impact on cognition of the use of antipsychotics. Curr Med Res Opin 2002, 18:13-17.